Stanford spinout Balance Therapeutics just raised another $3 million from a single investor, according to a regulatory filing – bringing what appears to be a Series B round up to $21 million. The company is developing a drug that could, potentially, raise the IQ of a person with Down Syndrome 10 to 20 percent. Close […]
Stanford spinout Balance Therapeutics just raised $18 million for its therapy that could raise the IQ of people with intellectual disability. It’s using a small molecule drug that has been around for decades – GABA-A antagonists – but rationalizes the approach by delving deeper into the molecular underpinnings of what causes diseases like Down Syndrome and dementia. And it […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.